Oncology & Cancer

Tumor-specific therapy targets ovarian cancer

Nami Therapeutics Corporation, which gets its name from the Mandarin word for "nano," is committed to using nanotechnologies to make big advances in cancer therapy.

Medications

Targeted therapy slows progression of advanced prostate cancer

Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and potentially improve survival, paving the way for a new approach to treatment of the most common form of cancer ...

Medical research

How cancer breaks down your muscles

A solid tumor can cause muscle cells in the body to self-destruct. Many cancer patients die from the consequences. Now researchers are discovering more about how cancer cells in a tumor can take control of muscle cell wasting ...

Oncology & Cancer

Increased risk of prostate cancer in men with BRCA2 gene fault

Men with the BRCA2 gene fault have an increased risk of prostate cancer and could benefit from PSA (prostate specific antigen) testing to help detect the disease earlier, according to researchers funded by Cancer Research ...

Medical research

Meet BORIS: Possible new culprit in drug-resistant cancer

Like a Russian bot corrupting U.S. elections, or a new prime minister wreaking havoc in the U.K., a protein named BORIS is showing itself to be a malevolent player in some childhood cancers. New research fingers BORIS as ...

Oncology & Cancer

Protein decoy stymies lung cancer growth in mice, study finds

Scientists at Stanford and UC-San Francisco have developed an experimental drug that targets a currently untreatable type of lung cancer responsible for generating roughly 500,000 newly diagnosed cases worldwide each year.

page 2 from 23